Plato Investment Management Ltd Makes New $529,000 Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

Plato Investment Management Ltd bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,799 shares of the biotechnology company’s stock, valued at approximately $529,000.

Other institutional investors also recently modified their holdings of the company. ICA Group Wealth Management LLC bought a new stake in Axon Enterprise in the 4th quarter valued at about $26,000. Blue Trust Inc. boosted its stake in shares of Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after buying an additional 79 shares during the period. Trivant Custom Portfolio Group LLC acquired a new stake in Axon Enterprise during the first quarter worth approximately $31,000. First PREMIER Bank bought a new position in Axon Enterprise during the 1st quarter worth $33,000. Finally, Blue Bell Private Wealth Management LLC acquired a new position in Axon Enterprise in the 1st quarter valued at $41,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Down 1.3 %

NASDAQ AXON opened at $379.61 on Monday. Axon Enterprise, Inc. has a twelve month low of $189.12 and a twelve month high of $385.00. The business’s fifty day moving average is $338.92 and its 200 day moving average is $314.68. The company has a quick ratio of 2.52, a current ratio of 2.88 and a debt-to-equity ratio of 0.35. The company has a market cap of $28.69 billion, a price-to-earnings ratio of 111.00, a price-to-earnings-growth ratio of 10.30 and a beta of 0.94.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, beating analysts’ consensus estimates of $1.02 by $0.18. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The firm had revenue of $504.00 million for the quarter, compared to analyst estimates of $478.35 million. During the same period last year, the firm posted $0.80 earnings per share. The business’s revenue for the quarter was up 34.5% on a year-over-year basis. As a group, sell-side analysts expect that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CFO Brittany Bagley sold 4,338 shares of the firm’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the completion of the transaction, the chief financial officer now owns 98,825 shares of the company’s stock, valued at $37,449,733.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Axon Enterprise news, President Joshua Isner sold 25,811 shares of the company’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $359.84, for a total value of $9,287,830.24. Following the sale, the president now owns 228,166 shares in the company, valued at approximately $82,103,253.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Brittany Bagley sold 4,338 shares of the stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $378.95, for a total value of $1,643,885.10. Following the completion of the sale, the chief financial officer now directly owns 98,825 shares of the company’s stock, valued at approximately $37,449,733.75. The disclosure for this sale can be found here. Insiders have sold 316,981 shares of company stock valued at $115,281,744 in the last ninety days. 6.10% of the stock is currently owned by insiders.

Analyst Ratings Changes

AXON has been the topic of several analyst reports. Barclays increased their target price on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Jefferies Financial Group began coverage on shares of Axon Enterprise in a research note on Wednesday, July 17th. They set a “buy” rating and a $385.00 price objective on the stock. JMP Securities boosted their target price on shares of Axon Enterprise from $375.00 to $430.00 and gave the company an “outperform” rating in a research report on Thursday. Robert W. Baird increased their price target on shares of Axon Enterprise from $360.00 to $400.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 10th. Finally, Needham & Company LLC restated a “buy” rating and set a $400.00 price objective on shares of Axon Enterprise in a research report on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus target price of $365.38.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.